Cancer cells go up in flames—thanks to this deep-sea sugar Scientists have discovered a sugar compound from deep-sea bacteria that can destroy cancer cells in a dramatic way. This natural substance, produced by microbes living in the ocean, causes cancer cells to undergo a fiery form of cell death, essentially making them self-destruct. In lab tests and in mice with liver cancer, the compound not only stopped tumors from growing, but also activated the immune system to fight back. This finding could pave the way for entirely new cancer treatments based on sugars from marine organisms.

Scientists found an ocean microbe sugar that makes cancer cells explode via pyroptosis 💥🧬 A natural compound that kills tumors + boosts immunity—proof that nature holds powerful cures 🌊🌱 #CancerResearch #OceanScience #NatureHeals #BiotechBreakthrough

www.sciencedaily.com...

Mouse study links telomerase activity to a truncated RHAMM isoform, suggesting potential for safer modulation of cellular aging.

longevity.technology/news/new-rol...

#longevity #Telomeres #AgingScience #RegenerativeMedicine #BiotechBreakthrough

Transformation génétique, ex nihilo, bâtir vue d'allumage pour thérapies médicales : de l'antisécher à la réduction de la gésose cancer ! 🧬💊 #BiotechBreakthrough #HealthTech #GrantFunding learn how i got $1256 grant for my business: tinyurl.com/financialhel...

New biotech skincare breakthrough uses DNA technology to target aging signs early ✨ #SkinCareRevolution #BiotechBreakthrough Cheap & High Quality Makeup: cutt.ly/FrRrWxtI

Breaking: Biotech Skincare Revolution | New Tech Fusion Combats Aging & Skin Diseases | Forbes Investigation | #SkincareRevolution #BiotechBreakthrough Donate Us - pslk.net/amazonlink

Enveric Biosciences' EB-003 Shows Potential for Broader Neurological Treatment Applications | AI News Brew <p>CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ: ENVB), a biotechnology company focused on developing novel neuroplastogenic small-molecule therapeutics, has announced new data that expands the pote...

Enveric Biosciences' EB-003 Shows Potential for Broader Neurological Treatment Applications
ainewsbrew.com/article/4791

#EnvericBiosciences #EB003 #BiotechBreakthrough #NeurologicalTreatment #DrugDevelopment #CNSDisorders #MentalHealth #ParkinsonsResearch #MigraineTreatment #NASDAQNews

Scientists Build Miniature Liver That Actually Works A new 3D liver model replicates bile flow, fibrosis, and liver disease—opening a powerful path to better research and drug testing.

This miniature liver works like the real thing—draining bile, modeling fibrosis, and helping decode liver disease. The future of medicine may start in a droplet. #OrganoidRevolution #LiverDisease #BiotechBreakthrough

Multiple Myeloma Treatment Market Size, Growth Report 2035 Multiple Myeloma Treatment Market projected to grow at 4.97% CAGR, reaching USD 20.0 Billion by 2035. Top company industry analysis driving growth, trends, regions, opportunity, and global outlook 20...

🧬 Fighting cancer on all fronts! 💪 The Multiple Myeloma Treatment Market sees robust innovation in hematology care. 🔬
#MyelomaAwareness #CancerTreatment #BloodCancer #PrecisionOncology #BiotechBreakthrough

www.marketresearchfuture.com/reports/mult...

AI-Driven Discovery Paves Way for Potential Universal Dengue Vaccine in Austin, Texas | AI News Brew <p>AUSTIN, Texas - In a significant advancement for global health, ImmunoPrecise Antibodies Ltd. (IPA) has announced a breakthrough in the quest for a universal dengue vaccine. The company, headquarte...

AI-Driven Discovery Paves Way for Potential Universal Dengue Vaccine in Austin, Texas
ainewsbrew.com/article/4419

#AIinHealthcare #DengueVaccine #BiotechBreakthrough #GlobalHealth #ArtificialIntelligence

Hidden Proteins Offer New Hope Against Pancreatic Cancer MIT and Dana-Farber researchers have discovered hidden peptides unique to pancreatic tumors—offering new hope for tailored T cell therapies.

Hidden proteins in pancreatic tumors could be the key to one of cancer’s deadliest puzzles. #PancreaticCancer #Immunotherapy #BiotechBreakthrough

The Minotaur Molecule: Cracking Parkinson’s Mitochondrial Code Breakthrough research reveals how a protein-engineered chimera unlocks a key Parkinson’s drug target—potentially transforming treatment.

This “Minotaur molecule” trick may finally lead to a cure—not just for Parkinson’s, but for many diseases. #ParkinsonsResearch #MitochondriaMatters #BiotechBreakthrough

Dire Wolf RETURNS.

Scientists used ancient DNA to revive one of the most fearsome predators in history.

Are we witnessing evolution… or crossing a dangerous line?

Video Link: youtu.be/dbDG3L6Ro3E?...

#DireWolf #BiotechBreakthrough #AncientDNA

https://doi.org/10.1126/science.adp1779 No description available

Innovative diffusion technique creates potent TNFR1 antagonists/agonists with low picomolar affinity from random noise! #BiotechBreakthrough PMID:39636970, Science 2024, @ScienceMagazine https://doi.org/10.1126/science.adp1779 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪

Colossal Biosciences Brings The Dire Wolf Back From Extinction: A Game of Thrones Dream Come True In a twist that could have been ripped straight from the pages of George R.R. Martin’s A Song of Ice and Fire, the long-extinct dire wolf has made a jaw-dropping return to the land of the living.Thank...

Dire wolves are back, and Game of Thrones fans are losing it! Colossal Biosciences brings fantasy to life with Romulus, Remus, and Khaleesi. Science or sorcery?

#DireWolfRevival #ColossalBiosciences #GoTFans #DeExtinction #ScienceMeetsFantasy #GeorgeRRMartin #BiotechBreakthrough #WildlifeComeback

Fundraising 🇺🇸 Colossal Biosciences Secures $200M for De-Extinction Efforts Colossal Biosciences, a leading biotech firm in the USA, has successfully raised $200 million in Serie C funding from TWG Global. This financial boost positions the company for significant advancements in its innovative projects, contributing to its mission within the biotechnology sector.

Colossal Biosciences secures $200M funding: Advancing de-extinction 🧬

#ColossalBiosciences #SeriesCFunding #BiotechBreakthrough #DeExtinction

#CARTCellTherapy #Immunotherapy #CellTherapyRevolution #CancerImmunotherapy #AdvancedCancerCare #CARTCellResearch #NextGenTherapies #BiotechBreakthrough #CancerResearch #InnovativeMedicine #BloodCancerTreatment #MultipleMyelomaCare #LymphomaAwareness #LeukemiaSupport

CRISPR Clinical Trial Targets Sickle Cell at Its Genetic Roots - SynBioBeta

New hope for sickle cell patients emerges as CRISPR trial eliminates the need for donors and addresses the mutation directly.

#CancerTherapy #PrecisionMedicine #Cyanobacteria #BiotechBreakthrough